Sonoma Pharmaceuticals (SNOA) Return on Equity (2016 - 2022)
Sonoma Pharmaceuticals (SNOA) has 2 years of Return on Equity data on record, last reported at 3.42% in Q4 2012.
- For Q4 2012, Return on Equity rose 49228.0% year-over-year to 3.42%; the TTM value through Dec 2012 reached 3.42%, up 49228.0%, while the annual FY2012 figure was 17.75%, N/A changed from the prior year.
- Return on Equity reached 3.42% in Q4 2012 per SNOA's latest filing, down from 77.74% in the prior quarter.
- Across five years, Return on Equity topped out at 77.74% in Q3 2012 and bottomed at 495.7% in Q4 2011.